Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04653012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

Study acronym: EpiMicro
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment increased: 50 → 80 participants
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 4 entries
  2. Minor Re-verified, no change to tracked fieldsv3
  3. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Dec 1, 2022 to Feb 27, 2029
    • Study sites: 0 to 1
    • Study completion date: Dec 1, 2030 to Feb 27, 2031
    • Start date changed from estimate of Dec 1, 2020 to Feb 28, 2021
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical investigation. The recordings will also be used to study physiological mechanisms like sleep and different cognitive functions.
Trial Details
NCT Number NCT04653012
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions
(from sponsor)
Focal Epilepsy, Electrodes, Implanted, Cognitive Function, Neurophysiology
Related terms Epilepsies, Partial, Seizures
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov